Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SOLID FORMS OF CERDULATINIB
Document Type and Number:
WIPO Patent Application WO/2019/213606
Kind Code:
A3
Abstract:
Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.

Inventors:
PANDEY ANJALI (US)
NORTHEN JULIAN SCOTT (GB)
FERNANDES PHILIPPE (GB)
CHEN YING (US)
LU YUELIE (US)
KARABORNI SAMI (US)
KODERSHA GUS (US)
Application Number:
PCT/US2019/030717
Publication Date:
December 05, 2019
Filing Date:
May 03, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PORTOLA PHARM INC (US)
International Classes:
C07D239/48; A61K31/506; A61P35/00
Domestic Patent References:
WO2009145856A12009-12-03
Other References:
G. COFFEY ET AL: "The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 351, no. 3, 23 October 2014 (2014-10-23), pages 538 - 548, XP055334164, DOI: 10.1124/jpet.114.218164
ANONYMOUS: "Cerdulatinib HCl - InvivoChem", 1 January 2018 (2018-01-01), XP055597053, Retrieved from the Internet [retrieved on 20190617]
Attorney, Agent or Firm:
TANNER, Lorna L. et al. (US)
Download PDF: